Patent US4282210A successfully refreshed from Google Patents.
US4282210A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for the control of shipping fever pneumonia in cattle
Assignee: Wyeth Holdings LLC
•
Filing: 1979-12-20
•
Granted: 1981-08-04
•
Expires: 1999-12-20
Abstract
Abstract There is provided a method for the control of shipping fever pneumonia in cattle, comprising administering to said cattle an immunizing amount of an infectious bovine rhinotracheitis virus vaccine and a potentiating amount of a potentiator therefor, selected from the group consisting of pharmaceutically acceptable salts of dl 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole and pharmaceutically acceptable salts of 1(-)6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole. This invention also relates to a method for reducing morbidity associated with shipping fever pneumonia in cattle by the parenteral treatment of said cattle with from 2 mg/kg to 8 mg/kg of animal body weight of a pharmaceutically acceptable salt of dl 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole or 1(-)6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole and a prophylactically effective amount of infectious bovine rhinotracheitis virus vaccine.
Inventors
- 👤 Michael R. Irwin
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 10:37
CPC Classifications
A; A61; A61K; A61K39/00; A61K39/39; A61K2039/555; A61K2039/55511; Y; Y10; Y10S; Y10S424/00; Y10S424/813
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
73 words
A method for the control of shipping fever in cattle comprising parenterally administering to said animals from 2 mg/kg of body weight to 8 mg/kg of body weight of a pharmaceutically acceptable salt of a compound selected from the group consisting of dl 6-phenyl-2,3,5,6-tetrahydroimidazo-[2,1-b]thiazole and 1(-)6-phenyl-2,3,5,6-tetrahydroimidazo-[2,1-b]thiazole and, the same day or within 21 days thereafter, parenterally administering to said cattle an immunizing or prophylactically effective amount of an infectious bovine rhinotracheitis virus vaccine.
Claim 2
Independent Claim
73 words
A method for the control of shipping fever in cattle comprising parenterally administering to said animals from 2 mg/kg of body weight to 8 mg/kg of body weight of a pharmaceutically acceptable salt of a compound selected from the group consisting of dl 6-phenyl-2,3,5,6-tetrahydroimidazo-[2,1-b]thiazole and 1(-)6-phenyl-2,3,5,6-tetrahydroimidazo-[2,1-b]thiazole and, the same day or within 21 days thereafter, parenterally administering to said cattle an immunizing or prophylactically effective amount of an infectious bovine rhinotracheitis virus vaccine.
Claim 3
Dependent Claim
36 words
A method according to claim 1 wherein the infectious bovine rhinotracheitis virus vaccine is administered at a dose level which provides said treated animals with from 16,000 to 3,163,000 tissue culture infective dose (TCID 50 's).
Claim 4
Dependent Claim
34 words
A method according to claim 2 wherein the thiazole salt employed in said treatment is 1(-)6-phenyl-2,3,5,6-tetrahydroimidazo-[2,1-b]thiazole phosphate and is administered to said animals at the dose level of 6 mg/kg of animal body weight.
Claim 5
Independent Claim
59 words
A method for potentiating the activity of infectious bovine rhinotracheitis vaccine to control shipping fever in cattle comprising administering parenterally from 16,000 to 3,163,000 TCID 50 's of said vaccine and subsequently, parenterally administering to said cattle from 2 mg/kg of body weight to 8 mg/kg of body weight of a pharmaceutically acceptable salt of dl 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole or 1(-)6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole.
Claim 6
Independent Claim
59 words
A method for potentiating the activity of infectious bovine rhinotracheitis vaccine to control shipping fever in cattle comprising administering parenterally from 16,000 to 3,163,000 TCID 50 's of said vaccine and subsequently, parenterally administering to said cattle from 2 mg/kg of body weight to 8 mg/kg of body weight of a pharmaceutically acceptable salt of dl 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole or 1(-)6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole.
Claim 7
Dependent Claim
41 words
A method according to claim 4 wherein said thiazole is 1(-)6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole phosphate and is parenterally administered at a dose level of 6 mg/kg of animal body on the same day the infectious bovine rhinotracheitis virus vaccine is administered to said cattle.
References Cited (Backward Citations)
US3907986A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-08-03 | 1985-02-02 | 1985-08-04 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-08-03 | 1989-02-02 | 1989-08-04 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-08-03 | 1993-02-02 | 1993-08-04 | $7700.00 | Window Closed / Lapsed |